Associate Director, Scientific Publications Medical Writer-Viral Hepatitis & Inflammation at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's degree with over 10 years of experience or a Master's degree with over 8 years of experience. A strong background in scientific writing, medical terminology, and specialized knowledge in Viral Hepatitis, Chronic Liver Diseases, and Inflammation therapeutic areas is required. Familiarity with publication databases like Datavision and adherence to guidelines such as ICMJE, GPP, and CONSORT are essential. Demonstrated ability to manage multiple projects and meet deadlines in a fast-paced environment is also necessary.

Responsibilities

The Associate Director, Scientific Publications Medical Writer will collaborate with cross-functional teams to develop and write publications, including manuscripts, abstracts, and posters, related to Viral Hepatitis, Chronic Liver Diseases, and Inflammation. Responsibilities include editing and proofreading scientific content, ensuring accurate communication of Gilead Science data, and working with thought leaders to revise publications. The role also involves conducting literature searches, gathering data, ensuring compliance with publication guidelines, managing projects, and staying current with research developments in the field.

Skills

Medical Writing
Scientific Publications
Viral Hepatitis
Chronic Liver Diseases
Inflammation
Drug Development
Patient Access Programs

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI